Denker HW (2006) Potentiality of embryonic stem cells: an ethical problem even with alternative
stem cell sources. J Med Ethics 32:665–671
Denker HW (2008) Totipotency/pluripotency and patentability. Stem Cells 26(6):1656–1657
Department of Health and Human Services (DHHS) (2001) Stem cells: scientific progress and
future research directions. http://stemcells.nih.gov/staticresources/info/scireport/PDFs/
fullrptstem.pdf. Accessed 22 June 2015
Dombrowski J (2012) Bundesgerichtshof rules that patents on embryonic stem cells are partially
valid. http://www.eplawpatentblog.com/eplaw/2012/11/de-bundesgerichtshof-rules-that-pat
ents-on-embryonic-stem-cells-are-partially-valid-.html. Accessed 12 June 2015
Eisenberg RS (2000) Re-examining the role of patents in appropriating the value of DNA
sequences. Emory Law J 49(3):783–800
Enlarged Board of Appeal of the European Patent Office (EBA) (2008) Decision in G 0002/06
Stem Cells/WARF. http://www.epo.org/law-practice/case-law-appeals/pdf/g060002ex1.pdf.
Accessed 12 June 2015
European Court of Human Rights (ECHR) (2004) Vo versus France, 53924/00, 08.07.2004.,http://
hudoc.echr.coe.int/sites/eng/pages/search.aspx?i¼001-61887#{%22itemid%22:[%22001-
61887%22]}. Accessed 12 June 2015
European Court of Justice (ECJ) (2001) Judgment of the Court of 9 October 2001. C-377/98
Kingdom of the Netherlands v European Parliament and Council of the European Union.http://
curia.europa.eu/juris/liste.jsf?language¼en&num¼C-377/98. Accessed 12 June 2015
European Group on Ethics in Science and New Technologies to the European Commission (EGE)
(1998) Opinion No. 12: Ethical Aspects of Research Involving the Use of Human Embryo in
the Context of the 5th Framework Programme, 23 November 1998
European Group on Ethics in Science and New Technologies to the European Commission (EGE)
(2000) Ethical Aspects of Human Stem Cells Research and Use (opinion). 14.11.2000
European Group on Ethics in Science and New Technologies to the European Commission (EGE)
(2002) Ethical aspects of patenting inventions involving human stem cells: Opinion no. 16.
http://www.unal.edu.co/bioetica/documentos/6_4.pdf. Accessed 12 June 2015
EuroStemCell (2012) Regulation of stem cell research in Europe.http://www.eurostemcell.org/.
Accessed 12 June 2015
Herdegen M (2002) Patents on parts of the human body: salient issues under EC and WTO law. J
World Intellect Prop 5(2):145–155
Jones JM, Thomson JA (2000) Human embryonic stem cell technology. Semin Reprod Med 18
(02):219–224
Medical Research Act of Finland (1998). http://www.finlex.fi/en/laki/kaannokset/1999/
en19990488.pdf. Accessed 12 June 2015
Minssen T, Nordberg A (2015) The evolution of the CJEU’s case law on stem cell patents: context,
outcome and implications of Case C-364/13 International Stem Cell Corporation, N I R 2015;(4)
Moufang R (1994) Patenting of human genes, cells and parts of the body? – The ethical dimensions
of patent law. IIC Int Rev Ind Prop Copyr Law 25(4):487–515
Mutabžija J (2014) Patentability of inventions involving human embryonic stem cells and cloning
according to the European Patent Convention. Dissertation, University of Zagreb, Zagreb
National Academies (NA) (2006) Understanding stem cells: an overview of the science and issues
from the national academies.http://www.annefjohnson.com/docs/stem_cells.pdf. Accessed
22 June 2015
National Institutes of Health (NIH) (2009) Stem cell information: The National Institutes of Health
Resource for Stem Cell Information. http://stemcells.nih.gov/staticresources/info/basics/
SCprimer2009.pdf. Accessed 22 June 2015
Pattinson SD, Caulfield T (2004) Variations and voids: the regulation of human cloning around the
world. BMC Med Ethics 5:9
Piirman M (2011) Patentability of inventions related to human embryonic stem cells. Juridica Int
18:94–103
78 J. Mutabžija